Stem Cell Therapy for Long COVID in Istanbul, Turkey

Laboratory work, any cardiology or respiratory review your case calls for, the number of infusions and the monitoring during your stay are quoted as separate lines rather than folded into one package figure, because the case review decides which of them apply to you. Our patient coordination team sends the itemized plan in writing before you book flights, states what it excludes, and tells you which follow-up contact is included once you are home.

The rationale is a coherent one and our medical team is comfortable setting it out: these cells are studied for immune and inflammatory signalling, and that is the part of Long COVID most current research points to. Clinical work specific to Long COVID is younger than the condition itself, and people respond differently, which is why your plan is written as goals with a measurement attached rather than as an expected result. We would rather tell you that before you travel than afterwards.

Your plan states it before you commit to flights: the assessment day, the number of infusions, the observation period after each one, and the rest days our team builds in for people who crash after exertion. Our patient coordination team confirms the dates, the daily timings and the total length of the visit in writing, and will space a schedule out rather than compress it where your history says that is wiser.

Closely, and our medical team assesses that overlap directly rather than around it. Many people with Long COVID meet the criteria used for myalgic encephalomyelitis and chronic fatigue syndrome, and post-viral fatigue after other infections follows a pattern anyone who has seen it recognises - the delayed crash after exertion above all. The overlap changes real things: the advice about pacing, the shape of the travel schedule, and which goals are sensible to write down. Where your picture sits closer to ME/CFS than to the breathlessness-led pattern, we say so and plan around it.

Yes. Our regenerative medicine program works with mesenchymal stromal cells (MSCs) grown from Wharton's jelly, the gelatinous tissue inside the umbilical cord. It is donated after a healthy birth with written maternal consent, from tissue that would otherwise be discarded, so nothing is taken from mother or baby and none of the ethical questions attached to embryonic sources arise. Because these cells expand readily in culture, a batch is characterised and release-tested before it reaches anyone. Your written plan names the material, how it is prepared, the dose, the route of administration and the schedule, and our medical team explains why each of those was chosen for your case.

Wharton's jelly is a young, perinatal tissue rather than an adult one, so the starting material does not carry the age or the health history of the person being treated, and nothing has to be harvested from you on the day. These cells also have a low-immunogenicity profile, which is why this source is studied for use between unrelated people. Most of all, they are strong secretors: the signalling molecules MSCs release are the mechanism most current research centres on, and that is what a plan is built around.

The length of stay follows your plan: the route of administration, the number of sessions, the monitoring after each one, and any mobility or assistance you need. Our patient coordination team confirms appointment dates, daily timings and the expected length of the visit in writing before you book flights.

No medical procedure is free of risk. Our medical team screens for infection, bleeding risk, medication interactions and other contraindications before treatment, explains the risks specific to the route used in your plan, and monitors you during administration and afterwards. If something makes treatment unsafe for you, we say so instead of proceeding.

Goals are set with you and described as aims, not results. Regenerative medicine treatments are planned individually, responses vary between patients and no clinical outcome can be guaranteed. Your plan states what will be measured, when it will be reviewed, and how treatment sits alongside the care you already receive.

Send your confirmed diagnosis, recent reports and imaging, your current medication list, previous procedures and the goals that matter to you. Our medical team reviews them remotely and comes back with an assessment of whether treatment in Istanbul is appropriate for your case, and what the next step would be.